HTA3 The Clinical and Economic Value of a Sustained Response in the Treatment of Moderate-to-Severe Psoriasis in Spain: The PSOVALUE Project

Autor: Hidalgo Vega, A, Zozaya, N, Merino, M, Abdalla, F, Maravilla, P, Alfonso Zamora, S, Balea Filgueiras, J, Carrascosa, JM, Delgado, O, Dolz Sinisterra, F, Garcia-Ruiz, AJ, Herranz Pinto, P, Manfredi, A, Martínez-Olmos, J, De los Ríos Luna, PM, Puig, L, Ros, S

Publikováno v: In Value in Health December 2022 25(12) Supplement:S296-S296

Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key Concepts.

Autor: Biundo E; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium., Dronova M; Putnam PHMR, 30-701 Krakow, Poland., Chicoye A; AC Health Consulting, Sciences Po, 75007 Paris, France., Cookson R; Centre for Health Economics, University of York, York YO10 5DD, UK., Devlin N; Health Economics Unit, Centre for Health Policy, University of Melbourne, Melbourne 3010, Australia., Doherty TM; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium., Garcia S; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium., Garcia-Ruiz AJ; Department of Pharmacology and Clinical Therapeutics, Faculty of Medicine, University of Malaga, 29071 Malaga, Spain., Garrison LP; School of Pharmacy, University of Washington, Seattle, WA 98195, USA., Nolan T; Health Economics Unit, Centre for Health Policy, University of Melbourne, Melbourne 3010, Australia., Postma M; Department of Health Sciences, University Medical Center Groningen, University of Groningen, 9700 AB Groningen, The Netherlands.; Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, 9713 AB Groningen, The Netherlands.; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung 40132, Indonesia., Salisbury D; Programme for Global Health, Royal Institute of International Affairs, Chatham House, London SW1Y 4LE, UK., Shah H; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium., Sheikh S; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium., Smith R; College of Medicine and Health, University of Exeter, Exeter EX1 2HZ, UK., Toumi M; Creativ-Ceutical, 1724 Luxembourg, Luxembourg., Wasem J; Institute for Health Care Management and Research, University of Duisburg-Essen, 45127 Essen, Germany., Beck E; GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium.

Publikováno v: Vaccines [Vaccines (Basel)] 2024 Jul 15; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 15.

Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.

Autor: Postma M; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, the Netherlands; Department of Pharmacology & Therapy, Universitas Airlangga, Surabaya, Indonesia; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia. Electronic address: m.j.postma@rug.nl., Biundo E; GSK, Wavre, Belgium. Electronic address: eliana.8.biundo@gsk.com., Chicoye A; AC Health Consulting, Sciences Po, Paris, France. Electronic address: annie.chicoye@gmail.com., Devlin N; University of Melbourne, Melbourne, Australia. Electronic address: nancy.devlin@unimelb.edu.au., Mark Doherty T; GSK, Wavre, Belgium. Electronic address: mark.x.doherty@gsk.com., Garcia-Ruiz AJ; University of Malaga, Malaga, Spain. Electronic address: ajgr@uma.es., Jaros P; Creativ-Ceutical, London, United Kingdom. Electronic address: Patrycja.Jaros@creativ-ceutical.com., Sheikh S; GSK, Wavre, Belgium. Electronic address: shazia.x.sheikh@gsk.com., Toumi M; Creativ-Ceutical, Luxembourg, Luxembourg. Electronic address: Mondher.Toumi@creativ-ceutical.com., Wasem J; University of Duisburg-Essen, Essen, Germany. Electronic address: juergen.wasem@medman.uni-due.de., Beck E; GSK, Wavre, Belgium. Electronic address: ekkehard.x.beck@gsk.com., Salisbury D; Programme for Global Health, Royal Institute of International Affairs, Chatham House, London, United Kingdom. Electronic address: david.salisbury@btinternet.com., Nolan T; University of Melbourne, Melbourne, Australia. Electronic address: t.nolan@unimelb.edu.au.

Publikováno v: Vaccine [Vaccine] 2022 Jun 26; Vol. 40 (30), pp. 3999-4007. Date of Electronic Publication: 2022 May 18.

[Pharmacoeconomic study of the treatment of advanced Parkinson's disease].

Autor: Vivancos-Matellano F; UAM. Universidad Autonoma de Madrid. Hospital Universitario La Paz, 28046 Madrid, Espana., Garcia-Ruiz AJ; Universidad de Malaga, Malaga, Espana., Garcia-Agua Soler N; Universidad de Malaga, Malaga, Espana.

Publikováno v: Revista de neurologia [Rev Neurol] 2016 Dec 16; Vol. 63 (12), pp. 529-536.

Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C.

Autor: Garcia Ruiz AJ; Laboratory of Cholinergic Neuropharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Zambelli M, La Porta C, Ladinsky H, Consolo S

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 1993 Jan 15; Vol. 244 (2), pp. 125-31.